CM
CVS icon

Castleark Management’s CVS Health CVS Stock Holding History

Castleark Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-291,200
Closed -$27.9M – 389
2016
Q2 		$27.9M Buy
291,200
+11,290
+4% +$1.13M 0.89% 31
2016
Q1 		$29M Sell
279,910
-299,440
-52% -$29.1M 0.91% 31
2015
Q4 		$56.6M Buy
579,350
+195,750
+51% +$19.2M 1.7% 7
2015
Q3 		$37M Buy
383,600
+260,000
+210% +$27.3M 1.19% 25
2015
Q2 		$13M Sell
123,600
-286,990
-70% -$29.3M 0.35% 90
2015
Q1 		$42.4M Sell
410,590
-213,310
-34% -$21.6M 1.02% 24
2014
Q4 		$60.1M Buy
+623,900
New +$55M 1.55% 14
2013
Q4 		– Sell
-1,047,720
Closed -$83.4M – 333
2013
Q3 		$83.4M Buy
+1,047,720
New +$62.4M 2.35% 3

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Castleark Management's CVS Position: Q3 2016 in Review

Castleark Management sold out of CVS Health (CVS) in Q3 2016, closing a stake of 291,200 shares — an estimated $27.9M sold.

Castleark Management first reported a position in CVS in Q3 2013 and held it in 8 quarters. The position peaked at $83.4M in Q3 2013. 1,564 funds tracked by Wall St. Rank hold CVS as of Q3 2016.

  • Castleark Management reported no remaining CVS Health position as of Q3 2016 after selling out during the quarter.
  • Castleark Management sold 291,200 CVS Health shares in Q3 2016, an estimated $27.9M.
  • Castleark Management first reported a position in CVS Health in Q3 2013 and held it in 8 quarters.
  • Castleark Management's CVS Health position peaked at $83.4M in Q3 2013.
  • 1,564 funds tracked by Wall St. Rank held CVS Health as of Q3 2016.

Based on Castleark Management's 13F filing for Q3 2016, filed 15 Nov 2016.